AHCO
AdaptHealth Corp.
Price Chart
Latest Quote
$10.10
Current Price| Previous Close | $10.05 |
| Open | $10.07 |
| Day High | $10.26 |
| Day Low | $9.98 |
| Volume | 883,887 |
Stock Information
| Shares Outstanding | 135.42M |
| Total Debt | $1.90B |
| Cash Equivalents | $81.12M |
| Revenue | $3.26B |
| Net Income | $75.29M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.37B |
| P/E Ratio | 18.36 |
| EPS (TTM) | $0.55 |
| Exchange | NCM |
📊 Custom Metrics & Score
Score: 15/42| Debt to Equity | 1.36 |
| Debt to Earnings | 3.13 |
| Current Ratio | 1.33 |
| Quick Ratio | 0.91 |
| Avg Revenue Growth | 8.21% |
| Profit Margin | 2.77% |
| Return on Equity | 5.76% |
| Avg FCF Growth | 56.45% |
| FCF Yield | 17.24% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $10.10 | 883,900 |
| 2026-01-30 | $10.05 | 957,200 |
| 2026-01-29 | $9.79 | 748,700 |
| 2026-01-28 | $9.62 | 949,800 |
| 2026-01-27 | $10.06 | 850,500 |
| 2026-01-26 | $10.23 | 824,000 |
| 2026-01-23 | $10.09 | 713,600 |
| 2026-01-22 | $10.50 | 1,004,600 |
| 2026-01-21 | $10.52 | 858,600 |
| 2026-01-20 | $10.40 | 832,400 |
| 2026-01-16 | $10.61 | 779,100 |
| 2026-01-15 | $10.64 | 790,900 |
| 2026-01-14 | $10.54 | 652,900 |
| 2026-01-13 | $10.61 | 757,900 |
| 2026-01-12 | $10.60 | 829,100 |
| 2026-01-09 | $10.49 | 735,500 |
| 2026-01-08 | $10.62 | 709,000 |
| 2026-01-07 | $10.50 | 1,094,200 |
| 2026-01-06 | $10.08 | 1,355,300 |
| 2026-01-05 | $9.78 | 870,300 |
About AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
📰 Latest News
Assessing AdaptHealth (AHCO) Valuation After Mixed Returns And A Large New Capitated Contract
Simply Wall St. • 2026-01-17T12:08:41Z
Is AdaptHealth (AHCO) Pricing Reflect Its DCF And P/E Signals After Recent Share Moves
Simply Wall St. • 2026-01-16T20:07:05Z
1 Safe-and-Steady Stock for Long-Term Investors and 2 We Avoid
StockStory • 2026-01-15T04:35:46Z
3 Russell 2000 Stocks We Find Risky
StockStory • 2026-01-13T04:31:25Z
3 Value Stocks with Questionable Fundamentals
StockStory • 2026-01-08T04:37:24Z
Senior Health, Home Health & Hospice Stocks Q3 Recap: Benchmarking AdaptHealth (NASDAQ:AHCO)
StockStory • 2026-01-07T03:37:09Z
Returns At AdaptHealth (NASDAQ:AHCO) Are On The Way Up
Simply Wall St. • 2026-01-06T11:47:38Z
3 Reasons to Avoid AHCO and 1 Stock to Buy Instead
StockStory • 2025-12-23T04:02:11Z
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 We Question
StockStory • 2025-12-15T04:40:18Z
1 Cash-Producing Stock to Keep an Eye On and 2 We Question
StockStory • 2025-12-12T04:38:03Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $2,259,593,000 | $2,250,414,000 | $2,104,192,000 | $1,813,967,000 |
| Cost Of Revenue | $2,579,882,000 | $2,576,110,000 | $2,390,480,000 | $2,008,925,000 |
| Total Revenue | $3,260,975,000 | $3,200,177,000 | $2,970,595,000 | $2,454,535,000 |
| Operating Revenue | $3,260,975,000 | $3,200,177,000 | $2,970,595,000 | $2,454,535,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $126,668,000 | $130,299,000 | $109,414,000 | $95,195,000 |
| Total Expenses | $2,984,165,000 | $2,967,791,000 | $2,780,184,000 | $2,228,930,000 |
| Rent Expense Supplemental | $71,874,000 | $68,375,000 | $65,979,000 | $48,586,000 |
| Other Income Expense | $-14,123,000 | $-825,871,000 | $16,905,000 | $60,549,000 |
| Other Non Operating Income Expenses | $-2,793,000 | $-29,566,000 | $-253,000 | $-1,832,000 |
| Net Non Operating Interest Income Expense | $-126,668,000 | $-130,299,000 | $-109,414,000 | $-95,195,000 |
| Interest Expense Non Operating | $126,668,000 | $130,299,000 | $109,414,000 | $95,195,000 |
| Operating Expense | $404,283,000 | $391,681,000 | $389,704,000 | $220,005,000 |
| General And Administrative Expense | $359,238,000 | $334,594,000 | $324,814,000 | $167,505,000 |
| Other Operating Expenses | - | - | - | $-10,595,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $90,422,000 | $-678,895,000 | $69,316,000 | $156,175,000 |
| Net Interest Income | $-126,668,000 | $-130,299,000 | $-109,414,000 | $-95,195,000 |
| Normalized Income | $98,319,010 | $63,261,260 | $56,498,974 | $104,523,532 |
| Net Income From Continuing And Discontinued Operation | $90,422,000 | $-678,895,000 | $69,316,000 | $156,175,000 |
| Total Operating Income As Reported | $263,732,000 | $-598,401,000 | $190,411,000 | $225,605,000 |
| Average Dilution Earnings | $0 | $-34,482,000 | $-17,158,000 | $-53,181,000 |
| Net Income Common Stockholders | $82,747,000 | $-678,895,000 | $63,449,000 | $141,796,000 |
| Net Income | $90,422,000 | $-678,895,000 | $69,316,000 | $156,175,000 |
| Net Income Including Noncontrolling Interests | $94,780,000 | $-674,780,000 | $73,133,000 | $158,153,000 |
| Net Income Continuous Operations | $94,780,000 | $-674,780,000 | $73,133,000 | $158,153,000 |
| Pretax Income | $136,019,000 | $-723,784,000 | $97,902,000 | $190,959,000 |
| Special Income Charges | $-15,351,000 | $-830,787,000 | $0 | $9,200,000 |
| Operating Income | $276,810,000 | $232,386,000 | $190,411,000 | $225,605,000 |
| Depreciation Amortization Depletion Income Statement | $45,045,000 | $57,087,000 | $64,890,000 | $63,095,000 |
| Depreciation And Amortization In Income Statement | $45,045,000 | $57,087,000 | $64,890,000 | $63,095,000 |
| Gross Profit | $681,093,000 | $624,067,000 | $580,115,000 | $445,610,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $0.61 | $-5.31 | $0.33 | $0.67 |
| Basic EPS | $0.62 | $-5.06 | $0.47 | $1.12 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-3,432,990 | $-54,148,740 | $4,340,974 | $10,729,532 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $639,351,000 | $585,603,000 | $541,336,000 | $481,826,000 |
| Total Unusual Items | $-11,330,000 | $-796,305,000 | $17,158,000 | $62,381,000 |
| Total Unusual Items Excluding Goodwill | $-11,330,000 | $-796,305,000 | $17,158,000 | $62,381,000 |
| Reconciled Depreciation | $365,334,000 | $382,783,000 | $351,178,000 | $258,053,000 |
| EBITDA (Bullshit earnings) | $628,021,000 | $-210,702,000 | $558,494,000 | $544,207,000 |
| EBIT | $262,687,000 | $-593,485,000 | $207,316,000 | $286,154,000 |
| Diluted Average Shares | $135,531,000 | $134,418,000 | $138,988,000 | $133,034,000 |
| Basic Average Shares | $133,756,000 | $134,156,000 | $134,175,000 | $126,306,000 |
| Diluted NI Availto Com Stockholders | $82,747,000 | $-713,377,000 | $46,291,000 | $88,615,000 |
| Preferred Stock Dividends | $7,675,000 | - | $5,867,000 | $14,379,000 |
| Minority Interests | $-4,358,000 | $-4,115,000 | $-3,817,000 | $-1,978,000 |
| Tax Provision | $41,239,000 | $-49,004,000 | $24,769,000 | $32,806,000 |
| Other Special Charges | $2,273,000 | - | - | $20,189,000 |
| Impairment Of Capital Assets | $13,078,000 | $830,787,000 | $0 | $0 |
| Gain On Sale Of Security | $4,021,000 | $34,482,000 | $17,158,000 | $53,181,000 |
| Selling General And Administration | $359,238,000 | $334,594,000 | $324,814,000 | $167,505,000 |
| Other Gand A | $359,238,000 | $334,594,000 | $324,814,000 | $167,505,000 |
| Otherunder Preferred Stock Dividend | - | $0 | $5,867,000 | $14,379,000 |
| Restructuring And Mergern Acquisition | - | $0 | $0 | $-29,389,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-1,209,569,000 | $-1,396,664,000 | $-1,556,912,000 | $-1,652,892,000 |
| Total Assets | $4,486,947,000 | $4,508,650,000 | $5,219,587,000 | $5,250,484,000 |
| Total Non Current Assets | $3,731,159,000 | $3,859,628,000 | $4,634,279,000 | $4,580,426,000 |
| Other Non Current Assets | $17,584,000 | $21,128,000 | $22,415,000 | $15,098,000 |
| Non Current Deferred Assets | $314,505,000 | $345,854,000 | $281,786,000 | $304,193,000 |
| Non Current Deferred Taxes Assets | $314,505,000 | $345,854,000 | $281,786,000 | $304,193,000 |
| Goodwill And Other Intangible Assets | $2,780,714,000 | $2,855,118,000 | $3,708,070,000 | $3,714,798,000 |
| Other Intangible Assets | $105,548,000 | $130,160,000 | $162,773,000 | $202,231,000 |
| Current Assets | $755,788,000 | $649,022,000 | $585,308,000 | $670,058,000 |
| Other Current Assets | $45,432,000 | $69,338,000 | $52,136,000 | $37,440,000 |
| Assets Held For Sale Current | $52,748,000 | $0 | - | - |
| Inventory | $139,842,000 | $113,642,000 | $127,754,000 | $123,095,000 |
| Receivables | $408,019,000 | $388,910,000 | $359,146,000 | $359,896,000 |
| Accounts Receivable | $408,019,000 | $388,910,000 | $359,146,000 | $359,896,000 |
| Cash Cash Equivalents And Short Term Investments | $109,747,000 | $77,132,000 | $46,272,000 | $149,627,000 |
| Cash And Cash Equivalents | $109,747,000 | $77,132,000 | $46,272,000 | $149,627,000 |
| Cash Equivalents | - | - | $0 | $14,000 |
| Cash Financial | - | - | $46,272,000 | $149,613,000 |
| Prepaid Assets | - | - | - | $37,440,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $1,871,424,000 | $2,070,850,000 | $2,141,995,000 | $2,053,925,000 |
| Total Debt | $2,130,336,000 | $2,294,649,000 | $2,328,823,000 | $2,370,596,000 |
| Long Term Debt And Capital Lease Obligation | $2,069,826,000 | $2,202,889,000 | $2,261,611,000 | $2,303,732,000 |
| Long Term Debt | $1,964,921,000 | $2,094,614,000 | $2,153,267,000 | $2,183,552,000 |
| Current Debt And Capital Lease Obligation | $60,510,000 | $91,760,000 | $67,212,000 | $66,864,000 |
| Current Debt | $16,250,000 | $53,368,000 | $35,000,000 | $20,000,000 |
| Other Current Borrowings | $16,250,000 | $53,368,000 | $35,000,000 | $20,000,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $2,908,829,000 | $3,041,981,000 | $3,061,829,000 | $3,183,795,000 |
| Total Non Current Liabilities Net Minority Interest | $2,341,842,000 | $2,504,982,000 | $2,605,615,000 | $2,683,983,000 |
| Other Non Current Liabilities | $272,016,000 | $302,093,000 | $305,501,000 | $322,487,000 |
| Current Liabilities | $566,987,000 | $536,999,000 | $456,214,000 | $499,812,000 |
| Other Current Liabilities | $33,548,000 | $14,675,000 | $19,863,000 | $43,194,000 |
| Current Deferred Liabilities | $34,944,000 | $38,570,000 | $31,641,000 | $31,370,000 |
| Payables And Accrued Expenses | $437,985,000 | $391,994,000 | $337,498,000 | $358,384,000 |
| Interest Payable | $28,818,000 | $29,327,000 | $28,877,000 | $30,103,000 |
| Payables | $284,602,000 | $268,844,000 | $222,505,000 | $248,027,000 |
| Accounts Payable | $284,602,000 | $211,504,000 | $222,505,000 | $248,027,000 |
| Derivative Product Liabilities | - | $0 | $38,503,000 | $57,764,000 |
| Other Payable | - | $57,340,000 | $44,244,000 | $45,884,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $1,571,144,000 | $1,458,453,000 | $2,151,157,000 | $2,061,905,000 |
| Preferred Stock Equity | $1,000 | $1,000 | $1,000 | $1,000 |
| Total Equity Gross Minority Interest | $1,578,118,000 | $1,466,669,000 | $2,157,758,000 | $2,066,689,000 |
| Stockholders Equity | $1,571,145,000 | $1,458,454,000 | $2,151,158,000 | $2,061,906,000 |
| Gains Losses Not Affecting Retained Earnings | $2,253,000 | $4,356,000 | $8,693,000 | $-2,354,000 |
| Other Equity Adjustments | $2,253,000 | $4,356,000 | $8,693,000 | $-2,354,000 |
| Retained Earnings | $-562,178,000 | $-652,600,000 | $26,295,000 | $-43,021,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $2,935,035 | $3,935,035 | $750,835 | - |
| Ordinary Shares Number | $134,602,317 | $132,634,850 | $134,435,119 | $133,843,732 |
| Share Issued | $137,537,352 | $136,569,885 | $135,185,954 | $133,843,732 |
| Tangible Book Value | $-1,209,570,000 | $-1,396,665,000 | $-1,556,913,000 | $-1,652,893,000 |
| Invested Capital | $3,552,315,000 | $3,606,435,000 | $4,339,424,000 | $4,265,457,000 |
| Working Capital | $188,801,000 | $112,023,000 | $129,094,000 | $170,246,000 |
| Capital Lease Obligations | $149,165,000 | $146,667,000 | $140,556,000 | $167,044,000 |
| Total Capitalization | $3,536,066,000 | $3,553,068,000 | $4,304,425,000 | $4,245,458,000 |
| Minority Interest | $6,973,000 | $8,215,000 | $6,600,000 | $4,783,000 |
| Treasury Stock | $25,548,000 | $43,267,000 | $13,992,000 | $0 |
| Additional Paid In Capital | $2,156,604,000 | $2,149,951,000 | $2,130,148,000 | $2,107,267,000 |
| Capital Stock | $14,000 | $14,000 | $14,000 | $14,000 |
| Common Stock | $13,000 | $13,000 | $13,000 | $13,000 |
| Preferred Stock | $1,000 | $1,000 | $1,000 | $1,000 |
| Long Term Capital Lease Obligation | $104,905,000 | $108,275,000 | $108,344,000 | $120,180,000 |
| Current Deferred Revenue | $34,944,000 | $38,570,000 | $31,641,000 | $31,370,000 |
| Current Capital Lease Obligation | $44,260,000 | $38,392,000 | $32,212,000 | $46,864,000 |
| Current Accrued Expenses | $153,383,000 | $123,150,000 | $114,993,000 | $110,357,000 |
| Goodwill | $2,675,166,000 | $2,724,958,000 | $3,545,297,000 | $3,512,567,000 |
| Net PPE | $618,356,000 | $637,528,000 | $622,008,000 | $546,337,000 |
| Accumulated Depreciation | $-518,176,000 | $-436,981,000 | $-383,188,000 | $-221,604,000 |
| Gross PPE | $1,136,532,000 | $1,074,509,000 | $1,005,196,000 | $767,941,000 |
| Other Properties | $1,010,231,000 | $953,979,000 | $898,973,000 | $731,728,000 |
| Machinery Furniture Equipment | $126,301,000 | $120,530,000 | $106,223,000 | $36,213,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $235,784,000 | $143,203,000 | $-17,556,000 | $72,371,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $541,839,000 | $480,666,000 | $373,867,000 | $275,679,000 |
| Cash Flow From Continuing Operating Activities | $541,839,000 | $480,666,000 | $373,867,000 | $275,679,000 |
| Operating Gains Losses | $-2,115,000 | $-36,283,000 | $-20,094,000 | $-39,973,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-306,055,000 | $-337,463,000 | $-391,423,000 | $-203,308,000 |
| Investing Cash Flow | $-310,275,000 | $-357,278,000 | $-411,171,000 | $-1,824,753,000 |
| Cash Flow From Continuing Investing Activities | $-310,275,000 | $-357,278,000 | $-411,171,000 | $-1,824,753,000 |
| Net Other Investing Changes | $5,316,000 | - | - | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $0 | $-29,275,000 | $-13,992,000 | $0 |
| Financing Cash Flow | $-198,949,000 | $-92,528,000 | $-66,051,000 | $1,598,739,000 |
| Cash Flow From Continuing Financing Activities | $-198,949,000 | $-92,528,000 | $-66,051,000 | $1,598,739,000 |
| Net Other Financing Charges | $-20,825,000 | $-14,102,000 | $-20,009,000 | $-89,012,000 |
| Net Common Stock Issuance | $0 | $-29,275,000 | $-13,992,000 | $278,850,000 |
| Issuance Of Capital Stock | - | $0 | $0 | $278,850,000 |
| Common Stock Issuance | - | $0 | $0 | $278,850,000 |
| Cash Dividends Paid | - | - | - | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-433,342,000 | $-101,769,000 | $-36,176,000 | $-869,435,000 |
| Issuance Of Debt | $253,477,000 | $50,000,000 | $0 | $2,265,000,000 |
| Interest Paid Supplemental Data | $122,072,000 | $126,228,000 | $108,885,000 | $73,630,000 |
| Income Tax Paid Supplemental Data | $14,139,000 | $14,756,000 | $14,949,000 | $14,792,000 |
| End Cash Position | $109,747,000 | $77,132,000 | $46,272,000 | $149,627,000 |
| Beginning Cash Position | $77,132,000 | $46,272,000 | $149,627,000 | $99,962,000 |
| Changes In Cash | $32,615,000 | $30,860,000 | $-103,355,000 | $49,665,000 |
| Proceeds From Stock Option Exercised | $1,741,000 | $2,618,000 | $4,126,000 | $13,336,000 |
| Common Stock Payments | $0 | $-29,275,000 | $-13,992,000 | $0 |
| Net Issuance Payments Of Debt | $-179,865,000 | $-51,769,000 | $-36,176,000 | $1,395,565,000 |
| Net Long Term Debt Issuance | $-179,865,000 | $-51,769,000 | $-36,176,000 | $1,395,565,000 |
| Long Term Debt Payments | $-433,342,000 | $-101,769,000 | $-36,176,000 | $-869,435,000 |
| Long Term Debt Issuance | $253,477,000 | $50,000,000 | $0 | $2,265,000,000 |
| Net Investment Purchase And Sale | $0 | $-128,000 | $-731,000 | $-1,125,000 |
| Purchase Of Investment | $0 | $-128,000 | $-731,000 | $-1,125,000 |
| Net Business Purchase And Sale | $-9,536,000 | $-19,687,000 | $-19,017,000 | $-1,620,320,000 |
| Purchase Of Business | $-9,536,000 | $-19,687,000 | $-19,017,000 | $-1,620,320,000 |
| Net PPE Purchase And Sale | $-306,055,000 | $-337,463,000 | $-391,423,000 | $-203,308,000 |
| Purchase Of PPE | $-306,055,000 | $-337,463,000 | $-391,423,000 | $-203,308,000 |
| Change In Working Capital | $-26,059,000 | $-25,109,000 | $-107,996,000 | $-153,309,000 |
| Change In Other Current Liabilities | $898,000 | $8,527,000 | $-88,344,000 | $-111,426,000 |
| Change In Prepaid Assets | $27,325,000 | $-20,305,000 | $-13,143,000 | $2,731,000 |
| Change In Inventory | $-28,065,000 | $15,531,000 | $-6,300,000 | $-14,920,000 |
| Change In Receivables | $-26,217,000 | $-28,862,000 | $-209,000 | $-29,694,000 |
| Changes In Account Receivables | $-26,217,000 | $-28,862,000 | $-209,000 | $-29,694,000 |
| Other Non Cash Items | $49,892,000 | $43,395,000 | $37,213,000 | $5,052,000 |
| Stock Based Compensation | $14,880,000 | $22,468,000 | $22,397,000 | $25,323,000 |
| Asset Impairment Charge | $13,078,000 | $830,787,000 | $0 | $0 |
| Deferred Tax | $32,049,000 | $-62,595,000 | $18,036,000 | $22,380,000 |
| Deferred Income Tax | $32,049,000 | $-62,595,000 | $18,036,000 | $22,380,000 |
| Depreciation Amortization Depletion | $365,334,000 | $382,783,000 | $351,178,000 | $258,053,000 |
| Depreciation And Amortization | $365,334,000 | $382,783,000 | $351,178,000 | $258,053,000 |
| Gain Loss On Investment Securities | $-4,388,000 | $-36,283,000 | $-20,094,000 | $-56,108,000 |
| Net Income From Continuing Operations | $94,780,000 | $-674,780,000 | $73,133,000 | $158,153,000 |
| Sale Of Investment | - | - | $0 | $0 |
| Change In Other Working Capital | - | - | $-31,213,000 | $-28,043,000 |